SCHEMBL13876333

SCHEMBL13876333

CS(=O)(=O)c1ccc(-c2ccc(CNC(=O)c3ccc(Oc4cccc(C#N)c4)nc3)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.58
MAPK8 P45983 8/20 0.48
MAPK9 P45984 8/20 0.48
MAPK10 P53779 7/20 0.48
HRH3 Q9Y5N1 2/20 0.47
RORC P51449 1/20 0.46
VNN1 O95497 1/20 0.45
MLNR O43193 1/20 0.44
NR1H4 Q96RI1 1/20 0.43
KDM1A O60341 1/20 0.43
HDAC1 Q13547 1/20 0.43
PPARA Q07869 1/20 0.43
DYRK3 O43781 1/20 0.43
PRKD3 O94806 1/20 0.43
JUN P05412 1/20 0.43
CSF1R P07333 1/20 0.43
MAPK1 P28482 1/20 0.43
RPS27 P42677 1/20 0.43
PRKD2 Q9BZL6 1/20 0.43
OPRM1 P35372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13876489 0.89 EPHX2 (0.64) EPHX2MAPK8MAPK9MAPK10RORC
SCHEMBL13876481 0.84 EPHX2 (0.65) EPHX2NR1H4
SCHEMBL13876327 0.82 EPHX2 (0.60) EPHX2MAPK8MAPK9MAPK10NR1H4
SCHEMBL14456994 0.82 EPHX2 (0.66) EPHX2RORCNR1H4KDM1AHDAC1
SCHEMBL13876501 0.80 EPHX2 (0.59) EPHX2HRH3RORCVNN1NR1H4
SCHEMBL13876484 0.79 EPHX2 (0.69) EPHX2VNN1NR1H4PPARAOPRM1
SCHEMBL13876254 0.78 EPHX2 (0.62) EPHX2HRH3VNN1MLNRNR1H4
SCHEMBL13876485 0.78 EPHX2 (0.64) EPHX2RORCNR1H4OPRM1OPRD1
SCHEMBL10833690 0.78 HRH3 (0.50) HRH3MLNR
SCHEMBL13876377 0.76 HRH3 (0.58) EPHX2HRH3MLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 US disclosed
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 US disclosed
WO-2007098352-A2 SUBSTITUTED PYRIDINEAMIDE COMPOUNDS USEFUL AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors EPHX1, EPHX2, NCEH1 EPHX2 2/4885MAPK8 2623/4885MAPK9 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.